Trials / Conditions / Castleman's Disease
Castleman's Disease
8 registered clinical trials studyying Castleman's Disease — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH NCT05283993 | Peking University First Hospital | — |
| Recruiting | Registry for Adults With Plasma Cell Disorders (PCD's) NCT03717844 | UNC Lineberger Comprehensive Cancer Center | — |
| Recruiting | Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune NCT03300830 | National Cancer Institute (NCI) | — |
| Recruiting | International Registry for Patients With Castleman Disease NCT02817997 | University of Pennsylvania | — |
| Withdrawn | Castleman Disease Collaborative Network Biobank NCT02871050 | Castleman Disease Collaborative Network | — |
| Completed | Unlock the Cell: Castleman's Disease Flow Cytometry Study NCT02853968 | University of Pennsylvania | — |
| Unknown | Dose-escalation Study of Oral CX-4945 NCT00891280 | Cylene Pharmaceuticals | Phase 1 |
| Completed | A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demons NCT01183598 | Hoffmann-La Roche | Phase 1 |